Syngene International Ltd. (SYNGENE) News, Articles, Events & Latest Updates

Trade Spotlight | Your trading strategy for Syngene International, Poly Medicure, Raymond todayMoneycontrol • 2 months ago

We have seen breakout of consolidation range in Poly Medicure, which has formed long bullish candlestick pattern on the daily scale with above average volumes. The stock ended at fresh record closing high of Rs 1,222, rising 6.7 percent.

Share to Feed

Syngene Intl Consolidated June 2023 Net Sales at Rs 808.10 crore, up 25.38% Y-o-YMoneycontrol • 2 months ago

Strides Pharma sinks after subsidiary plans to divest manufacturing plantMoneycontrol • 3 months ago

The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.

Syngene to acquire plant from Stelis Biopharma for Rs 702 croreMoneycontrol • 3 months ago

The company has entered into a binding term sheet with Stelis to acquire its Bengaluru-based Unit 3 biologics manufacturing unit, Syngene said in a late night statement on Tuesday.

Buy Syngene International; target of Rs 740: ICICI DirectMoneycontrol • 5 months ago

ICICI Direct is bullish on Syngene International recommended buy rating on the stock with a target price of Rs 740 in its research report dated April 27, 2023.

Syngene Intl Consolidated March 2023 Net Sales at Rs 994.40 crore, up 31.17% Y-o-YMoneycontrol • 5 months ago

Syngene Intl Standalone March 2023 Net Sales at Rs 994.40 crore, up 31.07% Y-o-YMoneycontrol • 5 months ago

Supply of shares on the rise as large investors, promoters lower their stakes Moneycontrol • 7 months ago

Market participants expect the trend of block deals to intensify given the uncertain macro-economic outlook both at the global and domestic level

Syngene International sees 4 crore shares sold in block deal, Biocon likely sellerMoneycontrol • 8 months ago

As of December end, Biocon held 64.5 percent promoter stake in Syngene International. After the block deal, this will go down to 54.5 percent.

Biocon likely to sell 10% equity stake in Syngene on Feb 1 via block dealMoneycontrol • 8 months ago

The offer price band ranges around Rs 560 to Rs 562.30 per share. The company is likely to raise Rs 2,240 crore at lower end via the deal.

Watchers	90
52-Wk Low	534.57
52-Wk High	860.25

Market Cap	321.8B
Volume (M)	615,736.00
52-Wk High	860.25
52-Wk Low	534.57

SYNGENE.NSE Syngene International Ltd.

About

Feed

News

Sentiment

Fundamentals

Latest SYNGENE.NSE News